By Jenny Bryan27 April 2000
Cancer patients are not benefiting from the large number of new drugs available because purchasers will be reluctant to fund them until they have the NICE seal of approval. Jenny Bryan squares the circle
With a HSJ subscription you’ll unlock:
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud